Aspirin Use and the Risk of Cancer-In Reply
JAMA Oncol
.
2019 Jun 1;5(6):913.
doi: 10.1001/jamaoncol.2019.0633.
Authors
Tracey G Simon
1
2
3
,
Mollie E Barnard
4
,
Andrew T Chan
1
2
3
5
6
7
Affiliations
1
Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston.
2
Harvard Medical School, Boston, Massachusetts.
3
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston.
4
Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City.
5
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
6
Broad Institute, Boston, Massachusetts.
7
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston Massachusetts.
PMID:
31046070
DOI:
10.1001/jamaoncol.2019.0633
No abstract available
Publication types
Comment
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal
Aspirin
Carcinoma, Hepatocellular*
Humans
Liver Neoplasms*
Substances
Anti-Inflammatory Agents, Non-Steroidal
Aspirin
Grants and funding
K00 CA212222/CA/NCI NIH HHS/United States